Cite
MLA Citation
Steven G. DuBois et al.. “Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.” Journal of clinical oncology, vol. 39, no. 31, 2021, pp. 3506–3514. http://access.bl.uk/ark:/81055/vdc_100150610215.0x00003e